{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:27:38Z","timestamp":1791296858901,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T00:00:00Z","timestamp":1480291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Genet"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/ng.3723","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T20:22:27Z","timestamp":1480364547000},"page":"97-109","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":186,"title":["An iPSC-derived vascular model of Marfan syndrome identifies key mediators of smooth muscle cell death"],"prefix":"10.1038","volume":"49","author":[{"given":"Alessandra","family":"Granata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William George","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeline","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Sastry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5900-1209","authenticated-orcid":false,"given":"Sanjay","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,11,28]]},"reference":[{"key":"BFng3723_CR1","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1161\/01.CIR.11.3.321","volume":"11","author":"VA McKusick","year":"1955","unstructured":"McKusick, V.A. The cardiovascular aspects of Marfan's syndrome: a heritable disorder of connective tissue. Circulation 11, 321\u2013342 (1955).","journal-title":"Circulation"},{"key":"BFng3723_CR2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1056\/NEJM197904053001406","volume":"300","author":"RE Pyeritz","year":"1979","unstructured":"Pyeritz, R.E. & McKusick, V.A. The Marfan syndrome: diagnosis and management. N. Engl. J. Med. 300, 772\u2013777 (1979).","journal-title":"N. Engl. J. Med."},{"key":"BFng3723_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/ajmg.c.30068","volume":"139C","author":"HC Dietz","year":"2005","unstructured":"Dietz, H.C., Loeys, B., Carta, L. & Ramirez, F. Recent progress towards a molecular understanding of Marfan syndrome. Am. J. Med. Genet. C. Semin. Med. Genet. 139C, 4\u20139 (2005).","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"BFng3723_CR4","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1136\/jmg.2005.039669","volume":"43","author":"PN Robinson","year":"2006","unstructured":"Robinson, P.N. et al. The molecular genetics of Marfan syndrome and related disorders. J. Med. Genet. 43, 769\u2013787 (2006).","journal-title":"J. Med. Genet."},{"key":"BFng3723_CR5","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1161\/01.CIR.0000155243.70456.F4","volume":"111","author":"DM Milewicz","year":"2005","unstructured":"Milewicz, D.M., Dietz, H.C. & Miller, D.C. Treatment of aortic disease in patients with Marfan syndrome. Circulation 111, e150\u2013e157 (2005).","journal-title":"Circulation"},{"key":"BFng3723_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/352337a0","volume":"352","author":"HC Dietz","year":"1991","unstructured":"Dietz, H.C. et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 352, 337\u2013339 (1991).","journal-title":"Nature"},{"key":"BFng3723_CR7","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1038\/ng1097-218","volume":"17","author":"L Pereira","year":"1997","unstructured":"Pereira, L. et al. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat. Genet. 17, 218\u2013222 (1997).","journal-title":"Nat. Genet."},{"key":"BFng3723_CR8","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrm2262","volume":"8","author":"P ten Dijke","year":"2007","unstructured":"ten Dijke, P. & Arthur, H.M. Extracellular control of TGF\u03b2 signalling in vascular development and disease. Nat. Rev. Mol. Cell Biol. 8, 857\u2013869 (2007).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng3723_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/ng0303-331","volume":"33","author":"V Kaartinen","year":"2003","unstructured":"Kaartinen, V. & Warburton, D. Fibrillin controls TGF-\u03b2 activation. Nat. Genet. 33, 331\u2013332 (2003).","journal-title":"Nat. Genet."},{"key":"BFng3723_CR10","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.gde.2007.04.006","volume":"17","author":"F Ramirez","year":"2007","unstructured":"Ramirez, F. & Dietz, H.C. Marfan syndrome: from molecular pathogenesis to clinical treatment. Curr. Opin. Genet. Dev. 17, 252\u2013258 (2007).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"BFng3723_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1126\/science.1124287","volume":"312","author":"JP Habashi","year":"2006","unstructured":"Habashi, J.P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312, 117\u2013121 (2006).","journal-title":"Science"},{"key":"BFng3723_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng1116","volume":"33","author":"ER Neptune","year":"2003","unstructured":"Neptune, E.R. et al. Dysregulation of TGF-\u03b2 activation contributes to pathogenesis in Marfan syndrome. Nat. Genet. 33, 407\u2013411 (2003).","journal-title":"Nat. Genet."},{"key":"BFng3723_CR13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1159\/000151766","volume":"46","author":"JA Jones","year":"2009","unstructured":"Jones, J.A., Spinale, F.G. & Ikonomidis, J.S. Transforming growth factor-\u03b2 signaling in thoracic aortic aneurysm development: a paradox in pathogenesis. J. Vasc. Res. 46, 119\u2013137 (2009).","journal-title":"J. Vasc. Res."},{"key":"BFng3723_CR14","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1016\/j.febslet.2012.05.027","volume":"586","author":"JJ Doyle","year":"2012","unstructured":"Doyle, J.J., Gerber, E.E. & Dietz, H.C. Matrix-dependent perturbation of TGF\u03b2 signaling and disease. FEBS Lett. 586, 2003\u20132015 (2012).","journal-title":"FEBS Lett."},{"key":"BFng3723_CR15","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/ATVBAHA.114.305150","volume":"35","author":"JR Cook","year":"2015","unstructured":"Cook, J.R. et al. Dimorphic effects of transforming growth factor-\u03b2 signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 911\u2013917 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFng3723_CR16","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1056\/NEJMoa1404731","volume":"371","author":"RV Lacro","year":"2014","unstructured":"Lacro, R.V. et al. Atenolol versus losartan in children and young adults with Marfan's syndrome. N. Engl. J. Med. 371, 2061\u20132071 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFng3723_CR17","doi-asserted-by":"publisher","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","volume":"96","author":"L Pereira","year":"1999","unstructured":"Pereira, L. et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc. Natl. Acad. Sci. USA 96, 3819\u20133823 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3723_CR18","first-page":"1329","volume":"124","author":"JR Cook","year":"2014","unstructured":"Cook, J.R. et al. Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J. Clin. Invest. 124, 1329\u20131339 (2014).","journal-title":"J. Clin. Invest."},{"key":"BFng3723_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1126\/science.1192149","volume":"332","author":"TM Holm","year":"2011","unstructured":"Holm, T.M. et al. Noncanonical TGF\u03b2 signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 332, 358\u2013361 (2011).","journal-title":"Science"},{"key":"BFng3723_CR20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861\u2013872 (2007).","journal-title":"Cell"},{"key":"BFng3723_CR21","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/nprot.2014.059","volume":"9","author":"C Cheung","year":"2014","unstructured":"Cheung, C., Bernardo, A.S., Pedersen, R.A. & Sinha, S. Directed differentiation of embryonic origin-specific vascular smooth muscle subtypes from human pluripotent stem cells. Nat. Protoc. 9, 929\u2013938 (2014).","journal-title":"Nat. Protoc."},{"key":"BFng3723_CR22","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1086\/302582","volume":"65","author":"I Schrijver","year":"1999","unstructured":"Schrijver, I., Liu, W., Brenn, T., Furthmayr, H. & Francke, U. Cysteine substitutions in epidermal growth factor-like domains of fibrillin-1: distinct effects on biochemical and clinical phenotypes. Am. J. Hum. Genet. 65, 1007\u20131020 (1999).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng3723_CR23","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1086\/520125","volume":"81","author":"L Faivre","year":"2007","unstructured":"Faivre, L. et al. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am. J. Hum. Genet. 81, 454\u2013466 (2007).","journal-title":"Am. J. Hum. Genet."},{"key":"BFng3723_CR24","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1399-0004.2008.01007.x","volume":"74","author":"M Attanasio","year":"2008","unstructured":"Attanasio, M. et al. FBN1 mutation screening of patients with Marfan syndrome and related disorders: detection of 46 novel FBN1 mutations. Clin. Genet. 74, 39\u201346 (2008).","journal-title":"Clin. Genet."},{"key":"BFng3723_CR25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nbt.2107","volume":"30","author":"C Cheung","year":"2012","unstructured":"Cheung, C., Bernardo, A.S., Trotter, M.W.B., Pedersen, R.A. & Sinha, S. Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility. Nat. Biotechnol. 30, 165\u2013173 (2012).","journal-title":"Nat. Biotechnol."},{"key":"BFng3723_CR26","doi-asserted-by":"publisher","first-page":"e6082","DOI":"10.1371\/journal.pone.0006082","volume":"4","author":"L Vallier","year":"2009","unstructured":"Vallier, L. et al. Early cell fate decisions of human embryonic stem cells and mouse epiblast stem cells are controlled by the same signalling pathways. PLoS One 4, e6082 (2009).","journal-title":"PLoS One"},{"key":"BFng3723_CR27","doi-asserted-by":"publisher","first-page":"17467","DOI":"10.1016\/S0021-9258(18)45403-8","volume":"262","author":"M Laiho","year":"1987","unstructured":"Laiho, M., Saksela, O. & Keski-Oja, J. Transforming growth factor-beta induction of type-1 plasminogen activator inhibitor. Pericellular deposition and sensitivity to exogenous urokinase. J. Biol. Chem. 262, 17467\u201317474 (1987).","journal-title":"J. Biol. Chem."},{"key":"BFng3723_CR28","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1152\/physrev.00041.2003","volume":"84","author":"GK Owens","year":"2004","unstructured":"Owens, G.K., Kumar, M.S. & Wamhoff, B.R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol. Rev. 84, 767\u2013801 (2004).","journal-title":"Physiol. Rev."},{"key":"BFng3723_CR29","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000318804","volume":"48","author":"HT Syyong","year":"2011","unstructured":"Syyong, H.T., Chung, A.W.Y. & van Breemen, C. Marfan syndrome decreases Ca2+ wave frequency and vasoconstriction in murine mesenteric resistance arteries without changing underlying mechanisms. J. Vasc. Res. 48, 150\u2013162 (2011).","journal-title":"J. Vasc. Res."},{"key":"BFng3723_CR30","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1111\/j.1476-5381.2009.00439.x","volume":"158","author":"HT Syyong","year":"2009","unstructured":"Syyong, H.T., Chung, A.W.Y., Yang, H.H.C. & van Breemen, C. Dysfunction of endothelial and smooth muscle cells in small arteries of a mouse model of Marfan syndrome. Br. J. Pharmacol. 158, 1597\u20131608 (2009).","journal-title":"Br. J. Pharmacol."},{"key":"BFng3723_CR31","doi-asserted-by":"publisher","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","volume":"117","author":"MG Keane","year":"2008","unstructured":"Keane, M.G. & Pyeritz, R.E. Medical management of Marfan syndrome. Circulation 117, 2802\u20132813 (2008).","journal-title":"Circulation"},{"key":"BFng3723_CR32","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","volume":"101","author":"AWY Chung","year":"2007","unstructured":"Chung, A.W.Y. et al. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Circ. Res. 101, 512\u2013522 (2007).","journal-title":"Circ. Res."},{"key":"BFng3723_CR33","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/ATVBAHA.114.304412","volume":"35","author":"E Crosas-Molist","year":"2015","unstructured":"Crosas-Molist, E. et al. Vascular smooth muscle cell phenotypic changes in patients with Marfan syndrome. Arterioscler. Thromb. Vasc. Biol. 35, 960\u2013972 (2015).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFng3723_CR34","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1096\/fj.02-0687fje","volume":"17","author":"O Meilhac","year":"2003","unstructured":"Meilhac, O. et al. Pericellular plasmin induces smooth muscle cell anoikis. FASEB J. 17, 1301\u20131303 (2003).","journal-title":"FASEB J."},{"key":"BFng3723_CR35","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1073\/pnas.1113442109","volume":"109","author":"N Quarto","year":"2012","unstructured":"Quarto, N. et al. Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells. Proc. Natl. Acad. Sci. USA 109, 215\u2013220 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFng3723_CR36","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1161\/ATVBAHA.107.141069","volume":"27","author":"MW Majesky","year":"2007","unstructured":"Majesky, M.W. Developmental basis of vascular smooth muscle diversity. Arterioscler. Thromb. Vasc. Biol. 27, 1248\u20131258 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFng3723_CR37","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s00018-013-1554-3","volume":"71","author":"S Sinha","year":"2014","unstructured":"Sinha, S., Iyer, D. & Granata, A. Embryonic origins of human vascular smooth muscle cells: implications for in vitro modeling and clinical application. Cell. Mol. Life Sci. 71, 2271\u20132288 (2014).","journal-title":"Cell. Mol. Life Sci."},{"key":"BFng3723_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/cr.2008.326","volume":"19","author":"M-J Goumans","year":"2009","unstructured":"Goumans, M.-J., Liu, Z. & ten Dijke, P. TGF-\u03b2 signaling in vascular biology and dysfunction. Cell Res. 19, 116\u2013127 (2009).","journal-title":"Cell Res."},{"key":"BFng3723_CR39","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/ng1511","volume":"37","author":"BL Loeys","year":"2005","unstructured":"Loeys, B.L. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat. Genet. 37, 275\u2013281 (2005).","journal-title":"Nat. Genet."},{"key":"BFng3723_CR40","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1038\/ng.2421","volume":"44","author":"AJ Doyle","year":"2012","unstructured":"Doyle, A.J. et al. Mutations in the TGF-\u03b2 repressor SKI cause Shprintzen-Goldberg syndrome with aortic aneurysm. Nat. Genet. 44, 1249\u20131254 (2012).","journal-title":"Nat. Genet."},{"key":"BFng3723_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/ng.744","volume":"43","author":"IMBH van de Laar","year":"2011","unstructured":"van de Laar, I.M.B.H. et al. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat. Genet. 43, 121\u2013126 (2011).","journal-title":"Nat. Genet."},{"key":"BFng3723_CR42","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1101\/gad.14.2.163","volume":"14","author":"Q Yu","year":"2000","unstructured":"Yu, Q. & Stamenkovic, I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-\u03b2 and promotes tumor invasion and angiogenesis. Genes Dev. 14, 163\u2013176 (2000).","journal-title":"Genes Dev."},{"key":"BFng3723_CR43","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1126\/science.1192152","volume":"332","author":"JP Habashi","year":"2011","unstructured":"Habashi, J.P. et al. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 332, 361\u2013365 (2011).","journal-title":"Science"},{"key":"BFng3723_CR44","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","volume":"358","author":"BS Brooke","year":"2008","unstructured":"Brooke, B.S. et al. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N. Engl. J. Med. 358, 2787\u20132795 (2008).","journal-title":"N. Engl. J. Med."},{"key":"BFng3723_CR45","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.1093\/eurheartj\/ehv151","volume":"36","author":"O Milleron","year":"2015","unstructured":"Milleron, O. et al. Marfan Sartan: a randomized, double-blind, placebo-controlled trial. Eur. Heart J. 36, 2160\u20132166 (2015).","journal-title":"Eur. Heart J."},{"key":"BFng3723_CR46","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI115881","volume":"90","author":"GH Gibbons","year":"1992","unstructured":"Gibbons, G.H., Pratt, R.E. & Dzau, V.J. Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-\u03b21 expression determines growth response to angiotensin II. J. Clin. Invest. 90, 456\u2013461 (1992).","journal-title":"J. Clin. Invest."},{"key":"BFng3723_CR47","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bbrc.2005.11.060","volume":"339","author":"Y Zhou","year":"2006","unstructured":"Zhou, Y., Poczatek, M.H., Berecek, K.H. & Murphy-Ullrich, J.E. Thrombospondin 1 mediates angiotensin II induction of TGF-\u03b2 activation by cardiac and renal cells under both high and low glucose conditions. Biochem. Biophys. Res. Commun. 339, 633\u2013641 (2006).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFng3723_CR48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0031-6997(24)01471-6","volume":"52","author":"RM Touyz","year":"2000","unstructured":"Touyz, R.M. & Schiffrin, E.L. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol. Rev. 52, 639\u2013672 (2000).","journal-title":"Pharmacol. Rev."},{"key":"BFng3723_CR49","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1172\/JCI38136","volume":"120","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. TGF-\u03b2 activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J. Clin. Invest. 120, 422\u2013432 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFng3723_CR50","doi-asserted-by":"publisher","first-page":"5630","DOI":"10.1074\/jbc.M806962200","volume":"284","author":"L Carta","year":"2009","unstructured":"Carta, L. et al. p38 MAPK is an early determinant of promiscuous Smad2\/3 signaling in the aortas of fibrillin-1 (Fbn1)-null mice. J. Biol. Chem. 284, 5630\u20135636 (2009).","journal-title":"J. Biol. Chem."},{"key":"BFng3723_CR51","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.yjmcc.2007.06.001","volume":"43","author":"S Wassmann","year":"2007","unstructured":"Wassmann, S. et al. Induction of p53 by GKLF is essential for inhibition of proliferation of vascular smooth muscle cells. J. Mol. Cell. Cardiol. 43, 301\u2013307 (2007).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"BFng3723_CR52","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1161\/01.ATV.20.4.973","volume":"20","author":"JK Hsieh","year":"2000","unstructured":"Hsieh, J.K. et al. p53, p21(WAF1\/CIP1), and MDM2 involvement in the proliferation and apoptosis in an in vitro model of conditionally immortalized human vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20, 973\u2013981 (2000).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFng3723_CR53","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1549-8719.2010.00071.x","volume":"18","author":"PR Clark","year":"2011","unstructured":"Clark, P.R. et al. MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells. Microcirculation 18, 102\u2013117 (2011).","journal-title":"Microcirculation"},{"key":"BFng3723_CR54","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cellsig.2005.11.003","volume":"18","author":"X Wang","year":"2006","unstructured":"Wang, X. & Tournier, C. Regulation of cellular functions by the ERK5 signalling pathway. Cell. Signal. 18, 753\u2013760 (2006).","journal-title":"Cell. Signal."},{"key":"BFng3723_CR55","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nrm3896","volume":"15","author":"JD Humphrey","year":"2014","unstructured":"Humphrey, J.D., Dufresne, E.R. & Schwartz, M.A. Mechanotransduction and extracellular matrix homeostasis. Nat. Rev. Mol. Cell Biol. 15, 802\u2013812 (2014).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFng3723_CR56","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1253026","volume":"344","author":"JD Humphrey","year":"2014","unstructured":"Humphrey, J.D., Milewicz, D.M., Tellides, G. & Schwartz, M.A. Cell biology. Dysfunctional mechanosensing in aneurysms. Science 344, 477\u2013479 (2014).","journal-title":"Science"},{"key":"BFng3723_CR57","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1042\/BST0360257","volume":"36","author":"J Jovanovi\u0107","year":"2008","unstructured":"Jovanovi\u0107, J., Iqbal, S., Jensen, S., Mardon, H. & Handford, P. Fibrillin-integrin interactions in health and disease. Biochem. Soc. Trans. 36, 257\u2013262 (2008).","journal-title":"Biochem. Soc. Trans."},{"key":"BFng3723_CR58","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1161\/01.HYP.0000062882.42265.88","volume":"41","author":"F Wernig","year":"2003","unstructured":"Wernig, F., Mayr, M. & Xu, Q. Mechanical stretch-induced apoptosis in smooth muscle cells is mediated by \u03b21-integrin signaling pathways. Hypertension 41, 903\u2013911 (2003).","journal-title":"Hypertension"},{"key":"BFng3723_CR59","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1093\/nar\/gkp215","volume":"37","author":"F-O Desmet","year":"2009","unstructured":"Desmet, F.-O. et al. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 37, e67 (2009).","journal-title":"Nucleic Acids Res."},{"key":"BFng3723_CR60","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature05950","volume":"448","author":"IGM Brons","year":"2007","unstructured":"Brons, I.G.M. et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191\u2013195 (2007).","journal-title":"Nature"},{"key":"BFng3723_CR61","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1002\/hep.23506","volume":"51","author":"T Touboul","year":"2010","unstructured":"Touboul, T. et al. Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology 51, 1754\u20131765 (2010).","journal-title":"Hepatology"}],"container-title":["Nature Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ng.3723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ng.3723","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ng.3723.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T22:21:55Z","timestamp":1749766915000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ng.3723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,28]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFng3723"],"URL":"https:\/\/doi.org\/10.1038\/ng.3723","relation":{},"ISSN":["1061-4036","1546-1718"],"issn-type":[{"value":"1061-4036","type":"print"},{"value":"1546-1718","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,28]]},"assertion":[{"value":"20 February 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}